SCHEMBL7204424

SCHEMBL7204424

CCCCOC(=O)N1CSC[C@H]1C(=O)N[C@@H](CSCC1CCCCC1)C(=O)NC1CCN(C(=O)c2ccc(F)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 1/20 0.51
EPHX2 P34913 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 5/20 0.36
LMNA P02545 2/20 0.36
GAA P10253 1/20 0.35
ALOX15 P16050 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KMT2A Q03164 4/20 0.34
P2RY12 Q9H244 1/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
HPGD P15428 2/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 1/20 0.33
TSHR P16473 1/20 0.33
PRKAA2 P54646 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5117829 0.89 CACNA1B (0.47) CACNA1BEPHX2L3MBTL1ALDH1A1LMNA
SCHEMBL5113474 0.83 CACNA1B (0.50) CACNA1BEPHX2L3MBTL1ALDH1A1GAA
SCHEMBL5118112 0.78 CACNA1B (0.51) CACNA1BL3MBTL1LMNASMN1; SMN2DRD3
SCHEMBL5117010 0.78 EPHX2 (0.45) EPHX2L3MBTL1ALDH1A1LMNAKMT2A
SCHEMBL7768817 0.77 CACNA1B (0.57) CACNA1BL3MBTL1ALDH1A1LMNASMN1; SMN2
Hydrochloric Acid SCHEMBL4845373 0.76 CACNA1B (0.56) CACNA1BL3MBTL1ALDH1A1LMNASMN1; SMN2
SCHEMBL5114271 0.76 EPHX2 (0.46) EPHX2L3MBTL1ALDH1A1LMNAKMT2A
SCHEMBL6397109 0.75 CACNA1B (0.58) CACNA1BL3MBTL1ALDH1A1SMN1; SMN2TSHR
SCHEMBL5110983 0.75 CACNA1B (0.69) CACNA1BL3MBTL1ALDH1A1GAASMN1; SMN2
SCHEMBL5117571 0.75 CACNA1B (0.57) CACNA1BL3MBTL1ALDH1A1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6605608-B1 Such as n-(1-benzylpiperidin-4-yl)-3-cyclohexylmethylthio-2-((4R)-3-t -butoxycarbonylthiazolidin-4-ylcarbonylamino)propan-a mide; n-type calcium channel inhibitors ONO PHARMACEUTICAL CO., LTD (JP) 2003-08-12 US claimed